Objective: Therapeutic hypothermia is being clinically used to reduce neurologic deficits after cardiac arrest (CA). Patients receiving hypothermia after CA receive a wide-array of medications. During hypothermia, drug metabolism is markedly reduced. Little, however, is known about the impact of hypothermia on drug metabolism after rewarming. The objective of this study was to examine the effect of CA and hypothermia on the functional regulation of two major drug metabolizing cytochrome P450 (CYP) isoforms.
M ild hypothermia improves long-term neurologic outcome and reduces mortality when applied after outof-hospital cardiac arrest (CA) (1, 2) .
Benefits have also been observed in stroke, (3) traumatic brain injury, (4) and perinatal asphyxia with up to a 72 hrs duration of hypothermia (5) . Results from these trials have led to increasing clinical implementation with increased interest in the factors that may influence the outcome of safety and efficacy trials (6) .
Patients with CA receive an extensive pharmacotherapeutic regimen. Many of the medications are eliminated by hepatic cytochrome P450 (CYP) metabolism. Some of the drugs that rely on CYP elimination include amiodarone, calcium channel blockers, fentanyl, and midazolam. Several of these medications produce adverse drug reactions, which are difficult to diagnose in critically ill patients. During cooling (immediately applied after injury), CYP-mediated metabolism of drugs is decreased (7) (8) (9) . However, alterations in CYP metabolism in experimental models after rewarming have not been reported.
The CYP3A family metabolizes greater than 50% of clinically relevant drugs in humans (10) . CYP3A2 is regulated through transcriptional mechanisms, including via the pregnane X receptor (11) . CYP2E1 is also constitutively expressed in the rat liver and catalyzes the oxidation of drugs and environmental contaminants (12, 13) . Disease states with a potent acute phase response decrease the expression and activity of CYP3A2 and CYP2E1 (14, 15) . The downregulation of these enzyme systems is believed to be mediated by proinflammatory cytokines which decrease the basal transcriptional rates.
On the basis of these previous studies, we set out to examine the effects of CA and therapeutic hypothermia on hepatic CYP3A2 and CYP2E1 isoforms after rewarming. The purpose of this study was to examine the effects of CA and moderate, transient hypothermia on the functional activity and messenger RNA (mRNA) expression of CYP3A2 and CYP2E1 in the rat liver at 5 and 24 hrs after injury and to determine the effects of CA with and without hypothermia on the regulation of pregnane X receptor (PXR) target genes in the rat liver. We also evaluated the potential role for increased cytokines after CA on the transcriptional regulators, expression, and functional activity of CYP3A2 and CYP2E1.
Moderate hypothermia for 3 hrs was selected as a proof-of-concept study to determine whether CA in the presence or absence of hypothermia alters drug metabolism.
MATERIALS AND METHODS

Materials and Chemicals
6␤-hydroxytestosterone (6␤-OH TST) and 11␤-OH TST were purchased from Steraloids (Newport, RI). Solutions for nitric oxide analysis were purchased from EiCOM Corporation (San Diego, CA). Organic solvents were purchased from Thermo Fisher Scientific (Pittsburgh, PA). All other chemicals were purchased from Sigma Aldrich (St. Louis, MO).
Animal CA and Hypothermia Protocol
The University of Pittsburgh Animal Care and Use Committee approved all studies. Adult male Sprague-Dawley rats (body weight, 300 -400 g) were purchased from Harlan Laboratories (Indianapolis, IN). CA was produced as previously described by Katz et al (16) as modified by Fink et al (17) . Rats were anesthetized with 3% halothane, endotracheally intubated, and mechanically ventilated. Halothane concentration was then reduced 0.5%-1%. Mean arterial pressure was measured via the right femoral artery and the femoral veins were cannulated bilaterally for drug administration and sampling. Neuromuscular blockade was induced with vecuronium 2 mg/kg. Body temperature was measured by rectal probe. Halothane was washed out with 100% O 2 for 3 mins and room air for 2 mins and rats were randomized to receive anesthesia control normothermia (control), CA with normothermia (CA normothermia), or CA with hypothermia (CA hypothermia). Animals received a second dose of vecuronium 1 mg/kg intravenous (IV) and CA was initiated by disconnection of mechanical ventilation. Asphyxial arrest was conducted for 8 mins, with ϳ5 mins of asystole, confirmed by electrocardiogram (17) . Resuscitation was started by ventilator reconnection, IV epinephrine (0.005 mg/kg), IV bicarbonate (1 mEq/kg), and performing manual chest compressions for 1 min until restoration of spontaneous circulation. Halothane was not resumed after asphyxiation based on the known burst-suppression pattern on electroencephalogram (17) . Arterial blood gases and glucose were determined before asphyxia and at the end of rewarming. Acidosis was corrected via bicarbonate to maintain pH at 7.4.
After resuscitation, rats were maintained at 37°C or temperature was decreased to 30°C via surface cooling. Rats remained hypothermic for 3 hrs followed by 1 hr of rewarming. Control rats were maintained at 37°C and received the same surgery protocol without asphyxiation.
Rats were randomized to be killed at 5 hrs (1 hr after rewarming) or 24 hrs after injury (20 hr after rewarming) and liver tissue was excised. Blood samples (0.3 mL) were obtained at 60, 70, 90, 120, and 180 mins after injury. Rats randomized to the 24 hr kill group were weaned from ventilation at the end of rewarming. Thirty-six rats were used for this study, thereby providing an n ϭ 6 per group (control, CA normothermia, and CA hypothermia) at the 5 hrs and 24 hrs times, respectively.
Microsomal Preparation
Liver tissue was homogenized and microsomes were prepared by standard methods (18) . Total protein was determined by the method of Lowry et al (19) .
CYP3A2 Activity Analysis
Microsomal incubations contained 400 g protein, 1 mM nicotinaminde adenine dinucleotide phosphate and 250 M TST in a 1 mL volume. Samples were incubated for 10 mins at 37°C in a water bath. Reactions were stopped on ice and addition of internal standard, 11␤-OH TST (164 mol/L). 6␤-OH TST was determined as described previously (20) . 6␤-OH TST, 11␤-OH TST, and TST were separated using a NovaPak C-18 (5 m, 3.9 ϫ 150 mm) column with ultraviolet detection at 254 nm. The ratio of 6␤-OH TST to 11␤-OH TST was used for quantitation.
CYP2E1 Activity Analysis
Microsomal incubations contained 400 g protein, 1 mM nicotinaminde adenine dinucleotide phosphate and 400 mol/L of chlorzoxazone (CZN). Samples were incubated for 20 mins at 37°C in a water bath. Reactions were stopped by adding 50 L of 42.5% o-phosphoric acid and internal standard, umbelliferone (78 mol/L). 6-OH CZN was measured as described by Rockich et al (18) : CZN, umbelliferone, and 6-OH CZN were separated using a NovaPak C-18 (5 m, 3.9 ϫ 150 mm) column. Ultraviolet-detection was set at 287 nm for CZN and 296 nm for 6-OH CZN. The ratio of CZN or 6-OH CZN to umbelliferone was used for quantitation.
Northern blot Analysis and Realtime-Polymerase Chain Reaction
Total RNA was prepared from liver tissue using TRIZOL reagent (Invitrogen, Carlsbad, CA). Northern hybridization was carried out as previously described (21) . The probes of CYP3A2, CYP2E1 were cloned from wild-type mouse liver mRNA as described (22) . Northern blot analysis was performed as previously de-scribed (21, 23, 24) . The membranes were stripped and reprobed with glyceraldehyde 3-phosphate dehydrogenase cDNA as loading control (25) . Realtime polymerase chain reaction using predesigned Assay-On-Demand TaqMan reagents or SYBR Green was performed with the ABI 7300 Realtime Polymerase Chain Reaction System (26) . Sequences for the realtime polymerase chain reaction oligonucleotides are available upon request.
Analysis of Interleukin (IL)-6 Plasma Concentrations
IL-6 was measured in the plasma using an enzyme linked immunosorbent assay kit specific for Rat IL-6 (R&D Systems, Minneapolis, MN). The optical density was determined using a Victor-2 Plate Reader (PerkinElmer, Shelton, CT) set at 450 nm plus a correction at 540-570 nm.
Plasmid and Transient Transfection
The reporter plasmid (PGL3-CYP3A2-Luc) and the expression vector for the human pregnane X receptor (CMX-hPXR) have been described (23) . Transient transfection was performed on HepG2 cells as described (21, 24, 26) . For each well, the plasmid-Lipofectamine 2000 complex was formed by incubating 2.4 g of expression vector for the nuclear receptor and 4.8 g of reporter gene and 1.5 g of ␤-gal plasmid with 60 L of Lipofectamine 2000 at room temperature for 20 mins in serum-free Eagle's Minimum Essential Medium. After 12 hrs of incubation, the transfection medium was replaced with Eagle's Minimum Essential Medium that contains 10% fetal bovine serum and appropriate solvent or drugs. Cells were lysed 24 hrs later and assayed for luciferase and ␤-gal activities. Luciferase activity was normalized against the cotransfected and ␤-galactosidase activities.
Statistical Analysis
Physiologic variables and IL-6 concentrations were compared via repeated measures one-way analysis of variance with a Bonferroni correction. CYP2E1, CYP3A2, and PXR measures within each time period were compared via one-way analysis of variance with a Bonferroni correction. Comparisons were made between control, CA normothermia, and CA hypothermia groups within each kill time with six rats per treatment group. All analyses were conducted using the software program Prism (GraphPad Software, San Diego, CA).
RESULTS
Physiologic Variables
CA hypothermia rats were cooled to 30°C over 30 mins and maintained for 3 hrs followed by 1 h of rewarming ( Fig. 1 ). Physiologic parameters (mean arterial blood pressure, blood pH, PAO 2 , PACO 2 , and glucose) were measured (Table 1 ). No differences in physiologic parameters were observed before CA. Post-CA, the CA normothermia and CA hypothermia groups had an anticipated increase in PaO 2 and decrease in PaCO 2 (***p Ͻ 0.01) (17) . [Furthermore, post-CA/hypothermia values of PaO 2 and PaCO 2 in CA normothermia and CA hypothermia groups were significantly different from control (***p Ͻ 0.001).] Figure 2A depicts the microsomal 6␤-OH TST formation rate in control, CA normothermia, and CA hypothermia (n ϭ 6 per group) rats at 5 hrs after injury. 6␤-OH TST formation rates were not different between control (2388 Ϯ 513 pmol/mg/min), CA normothermia (2374 Ϯ 299 pmol/mg/min), and CA hypothermia (2521 Ϯ 689 pmol/mg/min) groups. Figure 2B , depicts the microsomal formation rate of 6␤-OH TST (n ϭ 6 per group) rats at 24h after injury. 6␤-OH TST formation rate was decreased in the CA normothermia compared to control rats (1484 Ϯ 942.9pmol/mg/min vs. 3174 Ϯ 965.4pmol/mg/min; *p Ͻ 0.05, respectively). 6␤-OH TST formation rate (4345 Ϯ 1198pmol/mg/min) was not different between CA hypothermia and control rats; however, a difference was observed between CA hypothermia and CA normothermia rats; ‡ p Ͻ 0.05.
Effect of Cardiac Arrest and Hypothermia on 6␤-Hydroxytestosterone Formation Rate
Effect of Cardiac Arrest and Hypothermia on CYP3A2 Expression
Rats killed at 5 h after injury in all three groups showed no difference in CYP3A2 mRNA expression ( Fig. 3B ). However, a decrease in CA normothermia group CYP3A2 mRNA expression compared with both control and CA hypothermia was observed at 24 hrs ( Fig.  3D ; n ϭ 6 per group; *p Ͻ 0.05). No difference was observed at 24 hrs in the CA hypothermia rats vs. control. 6␤-hydroxytestosterone formation rate as a measure of CYP3A2 functional activity in liver microsomes from control, cardiac arrest (CA) normothermia, and CA hypothermia treated rats. A, 6␤-hydroxytestosterone formation rate in rats killed at 5 hrs after injury (1 hr after rewarming). No differences were observed between groups. B, 6␤-hydroxytestosterone formation rate in rats killed at 24 hrs after injury (20 hrs after rewarming). A significant decrease in 6␤-hydroxytestosterone formation rate in CA normothermia rats was observed compared with both control and CA hypothermia; ‡ p Ͻ 0.05. 
Effect of Cardiac Arrest and Hypothermia on 6-Hydroxychlorzoxazone Formation Rate
No significant difference in 6-OH CZN formation rate was observed between control (1.59 Ϯ 0.34 nmol/mg/min), CA normothermia (1.62 Ϯ 0.31nmol/mg/min), and CA hypothermia (1.73 Ϯ 0.36 nmol/mg/min) groups (Fig. 4A) . At 24 hrs, CA normothermia showed a significant decrease in 6-OH CZN formation rate (0.47 Ϯ 0.10 nmol/mg/min) vs. control (0.85 Ϯ 0.14 nmol/mg/min) or CA hypothermia rats (0.93 Ϯ 0.36 nmol/mg/ min), whereas, 6-OH CZN formation rate was not different between CA hypothermia and control (Fig. 4B ).
Effect of Cardiac Arrest and Hypothermia on CYP2E1 mRNA Expression
Rats killed at 5 hrs after injury showed no difference in CYP2E1 mRNA expression ( Fig. 5 ; n ϭ 6 per group). A nonsignificant trend toward a decrease in CYP2E1 mRNA expression was observed at 24 hrs between CA normothermia vs. control and CA hypothermia ( Fig. 5 ).
Effect of Cardiac Arrest and Hypothermia on the Expression of PXR Target Genes
The mRNA expression of an organic anion transporter (Oatp2), UDP-glucu-ronosyltransferase (UGT1A1), and two CYP genes that are known to have common regulatory control by the pregnane X receptor were evaluated in the rat liver. Figure 6 depicts the mRNA expression of Oatp2, UGT1A1, CYP3A2, and CYP2C2 in the liver from control, CA normothermia, and CA hypothermia rats. A significant reduction in mRNA expression of Oatp2, CYP3A2, and CYP2C2 was observed in CA normothermia as compared with control animals. The expression of Oatp2, UGT1A1, CYP3A2, and CYP2C2 was increased in rats that received hypothermia after CA vs. normothermia. Figure 7 depicts the time-course of plasma concentrations of IL-6 in three treatment groups, control, CA normothermia, and CA hypothermia; n ϭ 6 per group. CA normothermia produced increases in IL-6 concentrations compared with control at 60, 70, and 90 min after injury; ***p Ͻ 0.001. When hypothermia was applied in the CA model, the rise in IL-6 plasma concentrations was attenuated and did not differ from control. A, 6-OH chlorzaoxazone formation rate at 5 hrs after injury. No differences were observed between groups. B, 6-OH chlorzaoxazone formation rate at 24 hrs after injury. Activity in CA normothermia was significantly decreased compared to both control and CA hypothermia; ‡ p Ͻ 0.05. that IL-6 (1 unit-100 units) significantly inhibits both the basal and inducible expression of the PGL3-rCYP3A2-Luc natural promoter. An IL-6 dose dependent reduction in luciferase activity was observed in both vehicle control and rifampin induced expression of the natural promoter.
Effect of Cardiac Arrest and Hypothermia on IL-6 Concentrations in Rat Plasma
Effect of IL-6 on hPXR Expression of CYP3A2 in HepG2 Cells
DISCUSSION
We report four significant findings. First, CA significantly decreases CYP3A2 and CYP2E1 activity 24 hrs after injury. Second, in IL-6 plasma concentrations increase after CA. Third, moderate hypothermia prevents the down-regulation of CYP3A2 and CYP2E1-metabolism and blocked the early increase in IL-6 after CA. Fourth, multiple PXR target genes follow a similar pattern of altered expression, which may be due to the effects of IL-6 on PXR activity in the gene regulatory region genes. These findings suggest that by decreasing IL-6 concentrations after CA, hypothermia may favorably alter the course of disease and normalize CYPdrug metabolism.
CA Produces a Decrease in Hepatic Activity and Expression of CYP3A2 and CYP2E1
CA decreased the activity of both CYP3A2 and CYP2E1 at 24 hrs. This change was paralleled by a decrease in CYP3A2 mRNA. This is the first reported results on CA effects on CYP-mediated metabolism; however, studies in other injury models show decreased functional Figure 5 . CYP2E1 messenger RNA (mRNA) hepatic expression in control, cardiac arrest (CA) normothermia, and CA hypothermia rat liver. A, CYP2E1 mRNA expression at 5 hrs after injury. B, no difference between groups (n ϭ 6). C, CYP2E1 mRNA expression at 24 hrs after injury. D, CYP2E1 relative hepatic expression in the CA normothermia rats compared to control and CA hypothermia. No significant difference was observed between treatment groups. Figure 6 . Expression levels of pregnane X receptor target genes were evaluated to determine the effect of cardiac arrest (CA) and hypothermia on drug metabolism and detoxification pathways. Real-time polymerase chain reaction analyses of liver RNA levels were determined from control, CA normothermia (CAN), and CA hypothermia (CAH), groups. The hepatic expression of Oatp2, CYP3A2, CYP 2C2, and UGT1A1 are presented as average with standard division from four to six rats per treatment. (*p Ͻ 0.05, **p Ͻ 0.01, ***p Ͻ 0.001).
Figure 7.
Plasma interleukin (IL)-6 levels in control, cardiac arrest (CA) normothermia, and CA hypothermia after injury. CA normothermia IL-6 plasma concentrations at 60, 70, and 90 mins after injury were significantly increased as compared to control or CA hypothermia (***p Ͻ 0.001). The CA mediated increase in plasma IL-6 was attenuated in the CA hypothermic animals. expression of CYP isoforms (15, 27, 28) . Toler et al (29) showed that cortical concussion decreases hepatic CYP2C11 and CYP3A mRNA expression to ϳ50% at 24 hrs. Similarly, we reported a significant reduction in hepatic CYP2E1 activity at 48h after traumatic brain injury (30) . These studies suggest that ischemic and traumatic injuries down-regulate CYP activity via changes in gene expression. These results are important given that amiodarone, fentanyl, and midazolam are highly dependent on CYP3A for the majority of their elimination.
CA Produces Increases in IL-6 Plasma Concentrations that Are Attenuated by Hypothermia After Injury
We found that CA produced an approximately ten-fold increase in IL-6 plasma concentrations after injury. These results are consistent with clinical studies that have described CA as a sepsis-like syndrome (31, 32) . IL-6 is a mediator of the hepatic acute phase response and a potent inhibitor of CYPs (33) . Other ischemia models have shown that increased plasma IL-6 after injury is associated with decreased CYP activity (15) . The addition of IL-6 to hepatocytes decreases the CYP2E1 and CYP3A2 mRNA (34) . Our data also show that hypothermia attenuated the CA-mediated increase in IL-6. Prior studies show that hypothermia reduced IL-6 levels in animal models of traumatic brain injury and hemorrhagic shock (35) . These data are consistent with the putative role of cytokines in the metabolic phase after CA, as proposed by Weisfeldt and Becker (36) . Thus, cytokine alterations after a global ischemic insult are likely to contribute to the reduction in the functional regulation of CYP3A2, and hypothermia attenuates this pathologic response.
Moderate Hypothermia Provides a Protective Effect on CYP3A2 and CYP2E1 Activity and Expression
Moderate hypothermia attenuated the CA-mediated reduction in CYP3A2 and CYP2E1. These results are consistent with a study in traumatic brain injury patients where the systemic clearance of phenytoin was reduced during cooling; however, after rewarming, the systemic clearance returned to normal (37) . Similarly, Nishida et al. recently reported that hepatic metabolism and biliary excretion was reduced during hypothermia, whereas renal filtration was unchanged at 32°C (38) . These studies suggest that the results in our model parallel observations in the limited number of clinical reports.
Our data suggest that several PXR target genes are similarly regulated and that IL-6 reduces PXR functional activity. IL-6 produces a greater reduction in Oatp2 and CYP3A11 expression in the PXRϩ/ϩ mice vs. the PXRϪ/Ϫ, thereby suggesting that IL-6-mediated down-regulation is via the PXR pathway (39) . Previous studies in hPXR transfected HepG2 cells containing the pGL3-3A4-Luc reporter demon-strated that lipopolysaccharide and TNF␣ down-regulation of CYP3A4 transcription is dependent on cytokine activation of NFB (40, 41) . These studies suggest that NFB directly inhibits the binding of PXR to its target regulatory sequence, inhibiting PXR responsive gene transcription. Future studies to delineate the potential relationship between individual cytokines, NFB, and PXR-regulated genes will yield additional insight into these mechanisms.
Limitations
One consideration in the interpretation of this work is the fact that these studies were conducted under moderate hypothermic temperatures (30°C) for 3 hrs. Temperatures of 30°C were targeted because of the 3-hr duration in this rat model. Clinical hypothermia for CA is conducted at mild hypothermic temperatures (32-35°C) for 12-72 hrs, whereas deep hypothermia during cardiac surgery targets core temperatures well below 30°C for short intervals. Therefore, 30°C temperatures were selected to maximize the effect of hypothermia given the short duration of hypothermia used. Our results provide proof-of-concept by demonstrating that therapeutic hypothermia attenuates the cytokine-mediated effects of CA on drug metabolizing enzymes. Future studies to delineate the effects of mild hypothermia for longer durations are needed.
CONCLUSIONS
We report that in addition to the known reduction in drug metabolism during therapeutic hypothermia, this therapy mitigates the pathologic reduction in metabolism after rewarming in the experimental CA rat model. Hypothermia also attenuates the large increases in plasma IL-6 concentration after CA. Although clinical data are needed to fully understand the effects of hypothermic therapy on the disposition of medications in CA patients, our data suggest that hypothermia-drug metabolic alterations are time dependent with reductions in metabolism during cooling and protection from CA-mediated down-regulation after rewarming. Thus, hypothermia-drug metabolic interactions are time dependent and are an important consideration in the pharmacotherapy of CA patients both during temperature reduction and after rewarming. Co-transfection of human pregnane X receptor (hPXR) and pGL 3 -rCYP3A2 natural promoter treated by human interleukin (IL)-6 in HepG2 cells showed suppression of PXR activation. HepG2 cells were co-transfected with 1.4 kb natural promoter pGL 3 -rCYP3A2-Luc reporter and hPXR. Transfected cells were treated with indicated IL-6 concentration and/or rifampicin (RIF)-10 mM for 24 hrs before luciferase assay. Results are shown as -fold induction over vehicle control, which are represented as mean Ϯ SD from hexaplicate assay. DMSO, dimethyl sulfoxide.
